Keyphrases
Pediatric
81%
Seizure
50%
N-methyl-D-aspartate Receptor (NMDAR)
49%
Encephalitis
47%
Autoimmune Encephalitis
40%
Acquired Demyelinating Syndromes
36%
Autoantibodies
36%
Epileptic Encephalopathy
33%
Antibody-mediated
31%
MOG-Ab
28%
Clinical Features
26%
N-methyl-D-aspartate Receptor Antibody
25%
LGI1
25%
Aquaporin-4 (AQP4)
24%
Onconeural Antibodies
24%
Autoimmune
24%
Magnetoencephalography
24%
Acute Disseminated Encephalomyelitis
24%
Epilepsy
23%
CASPR2
22%
Multiple Sclerosis
20%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
18%
Disease Course
18%
Myelin Oligodendrocyte Glycoprotein Antibody
17%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
17%
VGKC-complex
15%
Brain Networks
15%
Myelin Oligodendrocyte Glycoprotein
15%
Epileptic Seizure
14%
Central Nervous System
14%
Surveillance Studies
13%
Pediatric Autoimmune Encephalitis
13%
Acquired Demyelinating Disease
13%
Disease-modifying Therapy
13%
Encephalopathy
13%
Early Treatment
12%
Paraclinical
12%
AMPA Receptor (AMPAR)
12%
Demyelinating Diseases
11%
Optic Neuritis
11%
Pediatric Epilepsy
11%
Epileptiform Activity
10%
VGKC Antibody
10%
Antibody-negative
10%
Mouse Model
10%
Passive Transfer
10%
Autoimmune Epilepsy
10%
Pediatric multiple Sclerosis
10%
Rodent Models
10%
Contactin-2
10%
Neuroscience
Encephalitis
75%
Myelin Oligodendrocyte Glycoprotein
43%
Brain Disease
42%
Immunotherapy
40%
Autoantibodies
39%
Receptor Antibody
33%
Receptor
33%
Aspartic Acid
31%
In Vivo
30%
Contactin
27%
In Vitro
24%
Magnetoencephalography
24%
Multiple Sclerosis
21%
Leucine
21%
Central Nervous System
19%
Demyelinating Disease
18%
Nervous System Disorder
18%
Brain Network
18%
Acute Disseminated Encephalomyelitis
16%
Dextro Aspartic Acid
16%
Pediatric Epilepsy
13%
Behavior (Neuroscience)
13%
Magnetic Resonance Imaging
12%
Optic Neuritis
12%
Status Epilepticus
11%
Synaptic Transmission
11%
Neuromyelitis Optica
11%
Axonin 1
10%
Voltage-Gated Potassium Channel
10%
Aquaporin 4 Antibody
10%
Expanded Disability Status Scale
10%
Limbic Encephalitis
10%
Ictal
9%
Neurosteroid
9%
Stereotypic Movement Disorder
9%
Magnetic Resonance Imaging of Brain
9%
Neurophysiology
8%
Immune System Disorders
8%
Epileptic Seizure
7%
Intravenous Immunoglobulin
7%
Immunoglobulin G
6%
Electrophysiology
6%
Nerve Fiber
6%
Synapsin I
6%
Receptor Protein
6%
Relapsing Remitting Multiple Sclerosis
6%
Autoantigen
6%
Cognitive Function
6%
Magnetic Resonance Imaging
6%
Monoclonal Antibody
6%
Medicine and Dentistry
Pediatrics
100%
Multiple Sclerosis
32%
Epileptic Seizure
29%
Brain Disease
28%
Acute Disseminated Encephalomyelitis
23%
Diseases
23%
Myelin Oligodendrocyte Glycoprotein
23%
Aquaporin 4 Antibody
23%
Autoantibodies
21%
Encephalitis
19%
Allergic Encephalitis
19%
Clinical Feature
18%
Disease Course
17%
Magnetoencephalography
17%
Immunotherapy
16%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
16%
Receptor Antibody
15%
Magnetic Resonance Imaging
15%
Clinically Isolated Syndrome
14%
Central Nervous System
12%
Neuromyelitis Optica
10%
Dextro Aspartic Acid
10%
N Methyl-D-Aspartate Receptor
10%
Paraneoplastic Cerebellar Degeneration
10%
Pediatric Neurology
9%
Transverse Myelitis
9%
Voltage-Gated Potassium Channel
8%
Magnetic Resonance Imaging of Brain
8%
In Vitro
8%
Recurrent Disease
7%
Onset Age
7%
Epilepsy
6%
Neurologic Disease
6%
MOG Antibody Disease
6%
School-Age Children
6%
Treatment Response
6%
Brain Tissue
6%
Pediatric Epilepsy
6%
Autoantigen
6%
Endocrine Disease
6%
Perampanel
6%
Decanoic Acid
6%
Epileptiform Activity
6%
AMPA Receptor
6%
Psychological Outcome
6%
Basal Ganglia
6%
Disease Modifying Therapy
6%
Combination Therapy
6%
Clinical Research
6%
Cognitive Function
6%
